Gut Microbiota and Epilepsy: A Systematic Review on Their Relationship and Possible Therapeutics
The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Abstract
Dysbiosis of gut microbiota may lead to a range of diseases including neurological disorders. Thus, it is hypothesized that regulation of the intestinal microbiota may prevent or treat epilepsy. The purpose of this systematic review is to evaluate the evidence investigating the relationship between gut microbiota and epilepsy and possible interventions. A systematic review of the literature was done on four databases (PubMed, Scopus, EMBASE, and Web of Science). Study selection was restricted to original research articles while following the PRISMA guidelines. Six studies were selected. These studies cohesively support the interaction between gut microbiota and epileptic seizures. Gut microbiota analysis identified increases in Firmicutes, Proteobacteria, Verrucomicrobia, and Fusobacteria with decreases in Bacteroidetes and Actinobacteria in epileptic patients. Ketogenic diet, probiotics, and fecal microbiota transplantation (FMT) improved the dysbiosis of the gut microbiota and seizure activity. However, the studies either had a small sample size, lack of subject variability, or short study or follow-up period, which may question their reliability. Nevertheless, these limited studies conclusively suggest that gut microbiota diversity and dysbiosis may be involved in the pathology of epilepsy. Future studies providing more reliable and in depth insight into the gut microbial community will spark promising alternative therapies to current epilepsy treatment.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The conclusion of a systematic review conducted according to the PRISMA guidelines was that data cohesively support the interaction between gut microbiota and epilepsy [373].”
From The Role of Microbiota-Gut-Brain Axis in Neuropsychiatric and Neurological Disorders (2021) · cites this paper as [373]
In the citing paper
“Epileptic patients were also reported to have an increase in rare bacteria phyla and genera [373].”
From The Role of Microbiota-Gut-Brain Axis in Neuropsychiatric and Neurological Disorders (2021) · cites this paper as [373]
In the citing paper
“An increase in Firmicutes phyla and a decrease in Bacteroidetes and Actinobacteria phyla in patients suffering from epilepsy appear to be the most consistent findings across different studies.”
From The Role of Microbiota-Gut-Brain Axis in Neuropsychiatric and Neurological Disorders (2021) · cites this paper as [373]
Citations
Cites
PRISMA-P Group, Moher, D., Shamseer, L., Clarke, M., Ghersi, D., Liberati, A., Petticrew, M., Shekelle, P., & Stewart, L. A. (2015) · Systematic Reviews · doi:10.1186/2046-4053-4-1 · Cited by 26,223
Enterotypes of the human gut microbiome
MetaHIT Consortium (additional members), Arumugam, M., Raes, J., Pelletier, E., Le Paslier, D., Yamada, T., Mende, D. R., Fernandes, G. R., Tap, J., Bruls, T., et al. (2011) · Nature · doi:10.1038/nature09944 · Cited by 7,548
The gut microbiota shapes intestinal immune responses during health and disease
Round, J. L., & Mazmanian, S. K. (2009) · Nature Reviews Immunology · doi:10.1038/nri2515 · Cited by 5,029
SYRCLE’s risk of bias tool for animal studies
Hooijmans, C. R., Rovers, M. M., de Vries, R. B., Leenaars, M., Ritskes-Hoitinga, M., & Langendam, M. W. (2014) · BMC Medical Research Methodology · doi:10.1186/1471-2288-14-43 · Cited by 4,415
Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile
van Nood, E., Vrieze, A., Nieuwdorp, M., Fuentes, S., Zoetendal, E. G., de Vos, W. M., Visser, C. E., Kuijper, E. J., Bartelsman, J. F. W. M., Tijssen, J. G. P., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1205037 · Cited by 3,708
Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease
Sampson, T. R., Debelius, J. W., Thron, T., Janssen, S., Shastri, G. G., Ilhan, Z. E., Challis, C., Schretter, C. E., Rocha, S., Gradinaru, V., et al. (2016) · Cell · doi:10.1016/j.cell.2016.11.018 · Cited by 3,622
Gut Microbiota in Human Adults with Type 2 Diabetes Differs from Non-Diabetic Adults
Larsen, N., Vogensen, F. K., van den Berg, F. W. J., Nielsen, D. S., Andreasen, A. S., Pedersen, B. K., Al-Soud, W. A., Sørensen, S. J., Hansen, L. H., & Jakobsen, M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009085 · Cited by 2,952
The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems.
(2015) · PubMed Central · Cited by 2,540
Development of a critical appraisal tool to assess the quality of cross-sectional studies (AXIS)
Downes, M. J., Brennan, M. L., Williams, H. C., & Dean, R. S. (2016) · BMJ Open · doi:10.1136/bmjopen-2016-011458 · Cited by 2,376
Role of the gut microbiota in immunity and inflammatory disease
Kamada, N., Seo, S.-U., Chen, G. Y., & Núñez, G. (2013) · Nature reviews. Immunology · doi:10.1038/nri3430 · Cited by 2,256
Research works printed but not linked: 1
- Carabotti M., 2015, Ann. Gastroenterol., 28, 203
Cited by
The Role of Microbiota-Gut-Brain Axis in Neuropsychiatric and Neurological Disorders
Socała, K., Doboszewska, U., Szopa, A., Serefko, A., Włodarczyk, M., Zielińska, A., Poleszak, E., Fichna, J., & Wlaź, P. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105840 · Cited by 857
A Comprehensive Review on the Role of the Gut Microbiome in Human Neurological Disorders
Sorboni, S. G., Moghaddam, H. S., Jafarzadeh-Esfehani, R., & Soleimanpour, S. (2022) · Clinical Microbiology Reviews · doi:10.1128/cmr.00338-20 · Cited by 522
Probiotics and gut microbiome − Prospects and challenges in remediating heavy metal toxicity
Arun, K. B., Madhavan, A., Sindhu, R., Emmanual, S., Binod, P., Pugazhendhi, A., Sirohi, R., Rajasekharan, R., Awasthi, M. K., Gnansounou, E., et al. (2021) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2021.126676 · Cited by 154
Gut Microbiota Interaction with the Central Nervous System throughout Life
Ojeda, J., Ávila, A., & Vidal, P. M. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10061299 · Cited by 103
Role of Gut Microbiota in Neurological Disorders and Its Therapeutic Significance
Tiwari, P., Dwivedi, R., Bansal, M., Tripathi, M., & Dada, R. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12041650 · Cited by 117
Liang, L., Saunders, C., & Sanossian, N. (2023) · Food Science & Nutrition · doi:10.1002/fsn3.3229 · Cited by 85
“KD has been shown to improve epilepsy frequency or duration (Arulsamy et al., 2020).”
BackgroundInfluentialEvidences for a Role of Gut Microbiota in Pathogenesis and Management of Epilepsy
Amlerová, J., Šroubek, J., Angelucci, F., & Hort, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115576 · Cited by 60
Gut microbiota manipulation as an epilepsy treatment
Iannone, L. F., Gómez-Eguílaz, M., & Caro, C. D. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105897 · Cited by 40
Li, X., Wang, Q., Wu, D., Zhang, D., Li, S. C., Zhang, S.-W., Chen, X., & Li, W. (2022) · BMC Neuroscience · doi:10.1186/s12868-022-00690-3 · Cited by 31
“Emerging studies have indicated that reconstruction of the gut microbiota can have a positive effect on epileptic seizures [7].”
BackgroundFusco, F., Perottoni, S., Giordano, C., Riva, A., Iannone, L. F., Caro, C. D., Russo, E., Albani, D., & Striano, P. (2022) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10296 · Cited by 29
Jiao, D., Xu, L., Gu, Z., Yan, H., Shen, D., & Gu, X. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-23-01444 · Cited by 33
“Patients with four or fewer seizures per year had a greater abundance of Bifidobacterium and lactic acid bacteria than those with frequent seizures, suggesting that an imbalance in the intestinal flora may be linked to epilepsy (Arulsamy et al., 2020).”
BackgroundOuyang, Y., Chen, Y., Wang, G., Song, Y., Zhao, H., Xiao, B., Yang, Z., & Long, L. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.994270 · Cited by 27
Oliveira, M. E. T., Paulino, G. V. B., Júnior, E. D. D. S., Oliveira, F. A. D. S., Melo, V. M. M., Ursulino, J. S., de Aquino, T. M., Shetty, A. K., Landell, M. F., & Gitaí, D. L. G. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02984-3 · Cited by 26
Wang, X., Ma, R., Liu, X., & Zhang, Y. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.948599 · Cited by 30
“Gut dysbiosis changes the levels of neurotransmitters, metabolites, and activities in the gut and affects glial function, neuroinflammation, myelination, bloodbrain barrier permeability, and neurotransmission, leading to various neurological disorders (8, 13).”
BackgroundWang, J., Huang, L., Li, H., Chen, G., Yang, L. M., Wang, D., Han, H. J., Zheng, G., Wang, X., Liang, J., et al. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1237255 · Cited by 25
Epilepsy-associated comorbidities among adults: A plausible therapeutic role of gut microbiota
Arulsamy, A., & Shaikh, M. F. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105648 · Cited by 22
“Recent studies have suggested extra cerebral risk factors such as dysbiosis of the gut microbiota to play a pathological role in epilepsy development (Arulsamy et al., 2020; Dahlin and Prast-Nielsen, 2019; Lum et al., 2020), and thus may serve as a safer therapeutic target for”
BackgroundResultInfluentialSelf-citationWan, L., Yang, G., Zhang, S., Sun, Y., Li, Z., Wang, J., Shi, X., & Zou, L. (2021) · Translational Pediatrics · doi:10.21037/tp-20-384 · Cited by 21
“Two approaches can be used to regulate the composition of the IF in the treatment of epilepsy: a ketogenic diet (KD) and probiotics (23).”
MethodWang, Y., Xu, H., Jing, M., Hu, X., Wang, J., & Hua, Y. (2022) · Frontiers in Pediatrics · doi:10.3389/fped.2022.831944 · Cited by 20
Gut microbiota modification by diosgenin mediates antiepileptic effects in a mouse model of epilepsy
Li, X., Li, J., Ji, J., Li, S., Yao, X., Fan, H., & Yao, R. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.16033 · Cited by 20
“Analysis reveals decreased Bacteroidetes and Actinobacteria and increased Firmicutes, Proteobacteria, Verrucomicrobia, and Fusobacteria in epileptic patients (Arulsamy et al., 2020).”
Chojnowski, K., Opiełka, M., Urbanowicz, K., Zawadzka, M., Wangin, K., Smolenski, R. T., & Mazurkiewicz‐Bełdzińska, M. (2025) · Scientific Reports · doi:10.1038/s41598-025-99805-z · Cited by 19
Liu, T., Jia, F., Guo, Y., Wang, Q., Zhang, X., Chang, F., & Xie, Y. X. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1081591 · Cited by 19
“The gut microbiota plays a major role in epilepsy, and alteration or regulation through exogenous interventions may reduce or prevent epilepsy (Arulsamy et al., 2020).”
BackgroundResultChanges in gut flora in patients with epilepsy: a systematic review and meta-analysis
He, X., & Zhang, Y. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1480022 · Cited by 19
Gut–Brain Axis and Brain Microbiome Interactions from a Medical Perspective
Arneth, B. M. (2025) · Brain Sciences · doi:10.3390/brainsci15020167 · Cited by 18
“The gut–brain axis, where the gut and brain microbiomes interact, influences a person’s neurological health through multiple pathways [59–61].”
Zou, S., Li, Y., Zou, Q., Yang, M. S., Li, H., Niu, R., Lai, H., Wang, J., Yang, X., & Zhou, L. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1403892 · Cited by 15
Crosstalk between peripheral and the brain-resident immune components in epilepsy
Mu, X., Zhang, X., Gao, H., Gao, L., Li, Q., & Zhao, C. (2022) · Journal of Integrative Neuroscience · doi:10.31083/j.jin2101009 · Cited by 15
“Gut microbiota is regarded as an early biomarker of epilepsy [168] and there is a strong correlation between the two [169].”
BackgroundA long journey to treat epilepsy with the gut microbiota
Li, Q., Gu, Y., Liang, J., Yang, Z., & Qin, J. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1386205 · Cited by 15
Li, B., Ma, Y., Wang, X., Zhao, D., Wang, Z., Wang, G., Li, C., Yang, L., Ji, H., Liu, K., et al. (2024) · Neurochemical Research · doi:10.1007/s11064-024-04168-y · Cited by 14
“…change in epileptic rats fed a KD. Recent studies have demonstrated a decrease in Actinobacteria and an increase in Firmicutes in epilepsy patients [48], and the level of Actinobacteria was decreased in epilepsy patients, which is consistent with our findings; however, the level of Firmicutes did…”
Sánchez-de-Lara-Sánchez, S., & Sánchez‐Pérez, A. M. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220615 · Cited by 15
Bibliometric Visualization Analysis of Microbiome-Gut-Brain Axis from 2004 to 2020
Wang, H., Long, T., You, J., Li, P., & Xu, Q. (2022) · Medical Science Monitor · doi:10.12659/msm.936037 · Cited by 13
Huang, M., Liu, Y., Duan, R., Yin, J., & Cao, S. (2023) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2023.133267 · Cited by 11
Li, X., Ji, J., Li, J., Li, S., Luo, Q., Gu, M., Yin, X., Zhang, M., Fan, H., & Yao, R. (2025) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2025.101291 · Cited by 9
“Moreover, our data showing the reversal of these alterations with FMT are consistent with previous studies highlighting the therapeutic potential of microbiota interventions [41].”
Is the oral pathogen, Porphyromona gingivalis, associated to colorectal cancer?: a systematic review
Navarro-Sánchez, A., Nieto-Vitoria, M. Á., López-López, J. A., Martínez-Crespo, J. J., & Navarro‐Mateu, F. (2025) · BMC Cancer · doi:10.1186/s12885-025-13770-4 · Cited by 8
“Gut microbiota imbalances have also been associated with other cancers and a wide range of health outcomes, including immune, metabolic, neurological, and mental health conditions [10–19].”
Yuwattana, R., Suparan, K., Kerdphoo, S., Arunsak, B., Sanguansermsri, C., Katanyuwong, K., Chattipakorn, N., Wiwattanadittakul, N., & Chattipakorn, S. C. (2024) · Brain Research · doi:10.1016/j.brainres.2024.149367 · Cited by 7
wang, X., Liu, M., Cao, L., Huang, H., Yang, J., Zhang, H., pan, C., & Xu, Z. (2025) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2025.101150 · Cited by 10
“For clinical translation, multi-modal interventions — including FMT, probiotic/prebiotic administration, supplementation with microbial metabolites, and vagus nerve stimulation — have been explored in related fields (Arulsamy et al., 2020).”
Kowalcze, K., Dyńka, D., Klus, W., Dudzińska, M., & Paziewska, A. (2025) · Nutrients · doi:10.3390/nu18010031 · Cited by 6
“In an increasing number of studies an increase in the Firmicutes, Proteobacteria, Verrucomicrobia and Fusobacteria phyla is demonstrated in epileptic patients, while in the Bacteroidetes and Actinobacteria phyla a decrease occurred [109–111].”
Amidu, S. B., Boamah, V. E., Ekuadzi, E., & Mante, P. K. (2023) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-023-04211-5 · Cited by 5
“Our observations therefore align with the existing body of knowledge and lend credence to claims from prior research, affirming that a rich and diverse microbiota could potentially alleviate the severity of seizure activity, as corroborated by other studies conducted [3, 15, 14].”
ResultAssociation between dietary inflammatory index and epilepsy: findings from NHANES
Zhu, Y., & Lu, C. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2025.1599286 · Cited by 4
“Extensive evidence links changes in gut microbiota to epilepsy (46, 47).”
Yang, H., Liu, W., Gao, T., Liu, Q., Zhang, M., Liu, Y., Ma, X., Zhang, N., Shi, K., Duan, M., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1438645 · Cited by 4
“In the future, FMT could be used as a promising treatment for epilepsy if puri fi ed colony samples highly correlated with elevated epileptic thresholds are available.”
BackgroundResultInfluentialGut microbiota in epilepsy: How antibiotics induce dysbiosis and influence seizure susceptibility
Zou, S., Yang, X., & Zhou, L. (2025) · Microbiological Research · doi:10.1016/j.micres.2025.128225 · Cited by 4
Climate change, gut microbiome, and epilepsy—New paradigms beyond the gut-brain axis
Santangelo, A., Corsello, A., Villano, G., Diana, M. C., & Striano, P. (2026) · Frontiers in Neurology · doi:10.3389/fneur.2025.1726561 · Cited by 3
Various pharmacological agents in the pipeline against intractable epilepsy
Waris, A., Asim, M., Ullah, A., & Alhumaydhi, F. A. (2024) · Archiv der Pharmazie · doi:10.1002/ardp.202400229 · Cited by 3
Gündoğdu, A., Arıkan, M., Ulas, A., Koldaş, S. S., & Ece, G. T. (2025) · Next research. · doi:10.1016/j.nexres.2025.100846 · Cited by 3
Normal human microbiota and dysbiosis: Implications for health and disease
Božić, D. D., Milenković, M., Antić‐Stanković, J., Arsenović-Ranin, N., & Bufan, B. (2024) · Arhiv za farmaciju · doi:10.5937/arhfarm74-46612 · Cited by 4
Human Microbiota Impact on the Efficacy of Pharmacological Treatments: A Review
Siraj, M., Siraj, H., Miran, S., & Hussain, F. (2024) · Advances in medical technologies and clinical practice book series · doi:10.4018/979-8-3693-2333-5.ch011 · Cited by 4
Pharmacokinetic study of Q808 in rhesus monkey using liquid chromatography–tandem mass spectrometry
Xiao, N., Li, X., Li, W., Zhao, J., Li, Y., & Wang, L. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1433043 · Cited by 2
Simani, L., Hooshmandi, E., Hajisoltani, R., & Hooshmandi, S. (2026) · Reviews in the Neurosciences · doi:10.1515/revneuro-2025-0151 · Cited by 1
“The improvement in behavioral and cognitive function following probiotic treatment is mediated through mechanisms including increased BDNF levels, increased hippocampal neurogenesis, and regulation of synaptic activity in the CA1 and DG pathways (Arulsamy et al. 2020; Aygun et al. 2023).”
Zou, Q., Zhang, Y., Zou, S., Li, Y., Li, H., Yang, M. S., Lai, H., Niu, R., Yang, X., & Zhou, L. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1670694 · Cited by 1
Akkermansia muciniphila enhances washed microbiota transplantation in the treatment of epilepsy
Li, Q., He, R., Wang, X., Long, C., He, Z., Zhang, S., Liu, Y., Zhang, Z., Wu, J., Sun, G., et al. (2026) · Chinese Medical Journal · doi:10.1097/cm9.0000000000004146 · Cited by 2
“[5] This implies that roughly one-third of patients experience refractory seizures, enduring persistent seizures.”
Borrero, J. A. C., Aulestia, J. V. M., Espinoza, A. G., Alcivar, N. M. Y., Mora, R. G. V., & Abarca, F. L. P. (2024) · Sapienza International Journal of Interdisciplinary Studies · doi:10.51798/sijis.v5i2.758 · Cited by 2
“Consequently, refractory seizures that impair with everyday activities affect around one-third of epilepsy patients (Arulsamy et al. 2020).”
BackgroundMicrobiome and Neurological Disorders
Ijaz, M. U., Akbar, A., Ashraf, A., Yeni, D. K., Naz, H. U., & Shahid, M. (2024) · Springer eBooks · doi:10.1007/978-981-97-3790-1_9 · Cited by 3
Recent advances in understanding tourette syndrome, tic disorders and functional tics
(2023) · Frontiers research topics · doi:10.3389/978-2-8325-2164-9
Advances in Ketogenic Diet-Mediated Gut Flora in Epilepsy
卢, 豫. (2024) · Advances in Clinical Medicine · doi:10.12677/acm.2024.143815
Faecal transplantation in epilepsy patients.
-, P. S., -, D. M. A., & -, B. J. J. V. B. (2025) · International Journal on Science and Technology · doi:10.71097/ijsat.v16.i1.1404
Neurological Disorders and the Gut-Brain Axis
Chattopadhyay, M., Laskar, A., Rahaman, S. S., & Chanda, A. (2025) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815324549125010010
Manoppo, J. I. C., Salendu, P. M., & Yulanda, H. (2025) · medRxiv · doi:10.1101/2025.07.31.25332438
“GM imbalance can influence neurotransmission, neuroinflammation, blood–brain barrier (BBB) permeability, and microglial function [14,15].”
DRUG-RESISTANT EPILEPSY – CURRENT TREATMENT STRATEGIES AND FUTURE THERAPEUTIC PERSPECTIVES
Juniewicz, H., Kudlińska, Z., Łagowski, R., Kosęda, J., Jędrasiak, A., Piotrowski, J., Heryć, P., Kananowicz, K., Laska, Z., & Latour, M. (2025) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.3(47).2025.4053
Li, X., Wang, Q., Wu, D., Zhang, D.-W., Li, S.-C., Zhang, S.-W., Chen, X., & Li, W. (2022) · Figshare · doi:10.6084/m9.figshare.19120607
Gut Microbiota: A Novel Perspective Linking Lithium Exposure to Epilepsy Risk
吴, 祺. (2025) · Bioprocess · doi:10.12677/bp.2025.154034
Arthur, K., Amoah, R., Danquah, J., & Mante, P. K. (2026) · BMC Microbiology · doi:10.1186/s12866-026-04901-3
Zhang, X., Hu, X. M., Hao, X., Zhang, H., Tao, Z., & Liang, J. (2026) · Frontiers in Neurology · doi:10.3389/fneur.2026.1804171
“The specific enrichment of this phylum in epilepsy patients was further supported by Arulsamy et al. (23).”
Gut microbiota and brain health: Disease-specific pathways and emerging therapeutic strategies
Oriquat, G., Rizaev, J., Abdulqader, A. F., Kadhim, A. A., Jamuna, K. V., Singhal, D. K., Bainsal, N., & Mansurova, N. (2026) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2026.107407
THE GUT–BRAIN AXIS IN NEUROLOGICAL DISORDERS: FROM MICROBIAL DYSBIOSIS TO THERAPEUTIC INTERVENTION
Aggarwal, B., Pandey, N., Anand, S., & Swami, A. (2026) · Genetics and Molecular Research · doi:10.4238/11w51k53
Udaiyappan, J. P., Balakrishnan, R., Tamilarasan, M. M., & Subasri, P. (2026) · Food Frontiers · doi:10.1002/fft2.70376
Unraveling the Gut Microbiota Influence on Arsenic Toxicity and Detoxification
Pothuraju, N., Bhoomgari, R., Annem, R. R., & Naresh, P. (2026) · Indian Journal of Microbiology · doi:10.1007/s12088-026-01584-2
Khan, A., Ullah, Z., Siraj, M., Younas, S., Wahab, S., Waris, A., & Hong, S.-T. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-06227-7
Metadata
- Authors
- Arulsamy, A., Tan, Q. Y., Balasubramaniam, V., O’Brien, T. J., & Shaikh, M. F.
- Affiliations
- Monash University Malaysia (MY)
- Department of Neuroscience, Central Clinical School, Monash University, Melbourne, 3004 VIC, Australia
- Corresponding author
- Shaikh, Mohd. Farooq
- Venue
- ACS Chemical Neuroscience
- Publisher
- American Chemical Society (ACS)
- Published
- 2020-10-16
- Volume
- 11
- Issue
- 21
- Pages
- 3488-3498
- ISSN
- 1948-7193 (ISSN-L)
- OpenAlex
- W3092970479
- Cited by
- 65
- References
- 59
- Citations by year
- 2026: 10 · 2025: 15 · 2024: 14 · 2023: 8 · 2022: 13 · 2021: 5
- FWCI
- 0.62
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- ACS Chemical Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- gut microbiota, epilepsy, dysbiosis, epileptic seizures, ketogenic diet, probiotics, fecal microbiota transplantation, microbial diversity, Firmicutes, Bacteroidetes
- MeSH terms
- Gastrointestinal Microbiome, Epilepsy, Humans, Reproducibility of Results, Bacteroidetes, Dysbiosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.